The MARTINEX company guarantees quality, safety and efficacy of HYALREPAIR CHONDROREPARANT® preparations, that has been proven by the results of preclinical trials and clinical studies in leading scientific institutions and specialized clinics.
Good tolerability and proven efficacy of HYALREPAIR CHONDROREPARANT® in patients with musculoskeletal diseases
Convenient application scheme with increased intervals between procedures, that allows a specialist to determine the required number of injections per course
The possibility of increasing the patient's compliance when prescribing injection courses of intra- and extra-articular treatment thanks to the convenient application scheme
The only preparation based on stabilized hyaluronic acid and proteinogenic amino acids for injection treatment
HYALREPAIR CHONDROREPARANT® is registered in the State Register similarly to competitive products - as a medical product (Registration Certificate No. FSR 2010/06572 dated 14.12.2012).
Injectable preparations were officially launched to the Russian market in 2013, and are actively gaining popularity among practicing physicians and specialists focused on science-intensive innovations in modern medicine.